Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI±5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy.
Blanc, J Hubner, Richard A Li, C Wang-Gillam, A Bodoky, G Dean, A Shan, Y Jameson, G Macarulla, T Lee, K
Blanc, J
Hubner, Richard A
Li, C
Wang-Gillam, A
Bodoky, G
Dean, A
Shan, Y
Jameson, G
Macarulla, T
Lee, K
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2017-06
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI±5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy 2017, 28 (suppl_3) Ann Oncol